(Total Views: 457)
Posted On: 09/28/2022 1:00:58 PM
Post# of 69

$ALT News Article - Altimmune Announces First Dosing of All Subjects in Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight https://marketwirenews.com/news-releases/alti...75448.html


My Twitter: WhyteStocks